Home
Quanex Building Products
Quanex Building Products Announces Second Quarter 2025 Results and Reaffirms Full Year 2025 Guidance
Business
Jun 5 2025
18 min read

Quanex Building Products Announces Second Quarter 2025 Results and Reaffirms Full Year 2025 Guidance

news images

Seasonal Uptick Unfolding as Expected
Volume Growth in European Fenestration Segment
Results Again Lifted by Contribution from Tyman Acquisition
Tyman Integration Ahead of Timeline
Cost Synergy Target Increased to ~$45 Million

HOUSTON, June 05, 2025 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended April 30, 2025.

The Company reported the following selected financial results:

 

 

 

Three Months Ended April 30,

 

Six Months Ended April 30,

($ in millions, except per share data)

 

 

2025

 

2024

 

2025

 

2024

Net Sales

 

 

$452.5

 

$266.2

 

$852.5

 

$505.4

Gross Margin

 

 

$131.4

 

$66.2

 

$223.7

 

$117.7

Gross Margin %

 

 

29.0%

 

24.9%

 

26.2%

 

23.3%

Net Income

 

 

$20.5

 

$15.4

 

$5.6

 

$21.6

Diluted EPS

 

 

$0.44

 

$0.46

 

$0.12

 

$0.65

 

 

 

 

 

 

 

 

 

 

Adjusted Net Income

 

 

$27.9

 

$24.0

 

$36.8

 

$32.3

Adjusted Diluted EPS

 

 

$0.60

 

$0.73

 

$0.79

 

$0.98

Adjusted EBITDA

 

 

$61.9

 

$40.0

 

$100.5

 

$59.3

Adjusted EBITDA Margin %

 

 

13.7%

 

15.0%

 

11.8%

 

11.7%

 

 

 

 

 

 

 

 

 

 

Cash Provided by Operating Activities

 

 

$28.5

 

$33.1

 

$16.0

 

$36.9

Free Cash Flow

 

 

$13.6

 

$25.5

 

($10.6)

 

$19.8

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, Chairman, President and Chief Executive Officer, commented, “Our results for the second quarter of 2025 came in as expected and reflected normal seasonality in our business. Revenue in March was approximately 6% higher than February and revenue in April was approximately 9% higher than March. It was also encouraging to see volume growth in our European Fenestration segment during the second quarter of 2025. We continue to be pleased with the integration of Tyman, and are now confident we will deliver approximately $45 million in cost synergies over time, compared to our original target of $30 million within the first two years post-acquisition. On a run-rate basis, we see a path to achieving the original $30 million cost synergy target by early fiscal 2026. We also took advantage of our low stock price during the second quarter and spent over $23 million repurchasing our shares.

“Overall, despite the challenging macroeconomic environment, we expect the seasonal uptick in demand we witnessed in the second quarter to continue through the summer, and we are confident in our ability to mitigate any potential margin impact related to tariffs. In addition, any unexpected weakness in demand in the second half of 2025 could be somewhat offset by the realization of cost synergies faster than originally planned. Our near-term priorities remain unchanged, which include staying focused on the Tyman integration, capturing synergies, and generating cash flow to repurchase our stock and pay down debt.   Longer-term, we continue to expect that we will benefit from the release of pent-up demand as consumer confidence improves.”

Second Quarter Results Summary

Quanex reported net sales of $452.5 million during the three months ended April 30, 2025, which represents an increase of 70.0% compared to $266.2 million for the same period of 2024. The increase reflects the contribution from the Tyman acquisition that closed on August 1, 2024. Excluding the contribution from Tyman, net sales would have declined by 1.4% for the second quarter of 2025, mainly due to lower volume in North America. The Company reported a decrease in net sales of 5.5% for the second quarter of 2025 in its North American Fenestration segment. In its North American Cabinet Components segment, Quanex reported a marginal increase in net sales for the second quarter of 2025. Excluding foreign exchange impact, net sales increased by 7.9% in its European Fenestration segment. In addition, Quanex reported net sales of $190.1 million related to the Tyman acquisition during the second quarter of 2025. (See Sales Analysis table for additional information)

The increase in net income and EBITDA for the three months ended April 30, 2025, was mostly related to the contribution from the Tyman acquisition combined with the realization of related cost synergies.

Balance Sheet & Liquidity Update

As of April 30, 2025, the Company had total debt of $785.0 million and Quanex’s leverage ratio of Net Debt to LTM Adjusted EBITDA decreased to 3.2x.   As of April 30, 2025, the Company’s LTM Net Income was $17.1 million and LTM Adjusted EBITDA was $223.5 million (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

The leverage ratio for Quanex’s quarterly debt covenant compliance (“Debt Covenant Leverage Ratio”) for its lenders was 2.7x as of April 30, 2025. The Debt Covenant Leverage Ratio calculation is defined in the Company’s Amendment No. 1 to its Second Amended and Restated Credit Agreement (“Credit Agreement”), which was filed with the SEC on June 12, 2024. In general, the main difference is that the Debt Covenant Leverage Ratio excludes real-estate leases that are considered “finance” leases under U.S. GAAP and is calculated on a proforma basis to include Adjusted EBITDA from the Tyman acquisition, $30 million of EBITDA for the synergy target related to the acquisition, less realized synergies, and only cash from domestic subsidiaries.   Note that per the terms of the Credit Agreement, the quarterly Debt Covenant Leverage Ratio must be less than 3.75x through the fourth quarter of 2025 and less than 3.25x starting in the first fiscal quarter of 2026. The Debt Covenant Leverage Ratio would be 2.4x if calculated using the total cash and cash equivalents amount on the balance sheet as of April 30, 2024, and adjusting for the cash used to repurchase stock during the quarter.

Quanex’s liquidity was $289.0 million as of April 30, 2025, consisting of $62.6 million in cash on hand plus availability under its Senior Secured Revolving Credit Facility due 2029, less letters of credit outstanding.

Share Repurchases

Quanex’s Board authorized a $75 million share repurchase program in December of 2021. Repurchases under this program will be made in open market transactions or privately negotiated transactions, subject to market conditions, applicable legal requirements, and other relevant factors. The Company repurchased 1,259,407 shares of common stock for approximately $23.5 million at an average price of $18.66 per share during the three months ended April 30, 2025. As of April 30, 2025, approximately $35.6 million remained under the existing share repurchase authorization.

Outlook

Mr. Wilson stated, “Based on our results year-to-date, combined with our operational execution, cost synergy realization, recent demand trends, and conversations with our customers, we are once again reaffirming our guidance for fiscal 2025. On a consolidated basis for fiscal 2025, we continue to estimate that we will generate net sales of approximately $1.84 billion to $1.86 billion, which we expect will yield Adjusted EBITDA* of $270 million to $280 million.

“The finance and accounting teams continue to work with our external auditors on re-segmenting the business and our goal is to report in the new operating segments this year.”

*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company’s control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes related to net income.

Conference Call and Webcast Information

The Company has also scheduled a conference call for Friday, June 6, 2025 at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link:
https://register-conf.media-server.com/register/BI5c78744cb292420a807e6c6762cb6343

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, solar, refrigeration, custom mixing, building access and cabinetry markets.  Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

Non-GAAP Terminology Definitions and Disclaimers

Adjusted Net Income (defined as net income further adjusted to exclude amortization of step-up for purchase price adjustments on inventory, transaction, advisory fees and reorganization costs, restructuring charges related to severance and disposal of software, amortization expense related to intangible assets, pension settlement refund and other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making.  Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making.   Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities.  The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: impacts from public health issues (including pandemics) on the economy and the demand for Quanex’s products, timing estimates or any other expectations related to the acquisition of Tyman, the Company’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to Quanex’s industry, and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. For a complete discussion of factors that may affect Quanex’s future performance, please refer to the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2024, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.

 

 

 

 

 

 

 

 

 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended April 30,

 

Six Months Ended April 30,

 

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

452,478

 

 

$

266,201

 

 

$

852,522

 

 

$

505,356

 

Cost of sales

 

 

321,096

 

 

 

199,963

 

 

 

628,824

 

 

 

387,686

 

Selling, general and administrative

 

 

70,333

 

 

 

34,707

 

 

 

136,983

 

 

 

67,070

 

Restructuring charges

 

 

936

 

 

 

-

 

 

 

8,840

 

 

 

-

 

Depreciation and amortization

 

 

19,192

 

 

 

10,894

 

 

 

43,932

 

 

 

22,046

 

Operating income

 

 

40,921

 

 

 

20,637

 

 

 

33,943

 

 

 

28,554

 

Interest expense

 

 

(13,940

)

 

 

(950

)

 

 

(28,126

)

 

 

(2,018

)

Other, net

 

 

(159

)

 

 

4

 

 

 

1,070

 

 

 

1,046

 

Income before income taxes

 

 

26,822

 

 

 

19,691

 

 

 

6,887

 

 

 

27,582

 

Income tax expense

 

 

(6,307

)

 

 

(4,314

)

 

 

(1,257

)

 

 

(5,956

)

Net income

 

$

20,515

 

 

$

15,377

 

 

$

5,630

 

 

$

21,626

 

 

 

 

 

 

 

 

 

 

Earnings per common share, basic

 

$

0.44

 

 

$

0.47

 

 

$

0.12

 

 

$

0.66

 

Earnings per common share, diluted

 

$

0.44

 

 

$

0.46

 

 

$

0.12

 

 

$

0.65

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

Basic

 

 

46,483

 

 

 

32,870

 

 

 

46,753

 

 

 

32,847

 

Diluted

 

 

46,563

 

 

 

33,103

 

 

 

46,868

 

 

 

33,076

 

 

 

 

 

 

 

 

 

 

Cash dividends per share

 

$

0.08

 

 

$

0.08

 

 

$

0.16

 

 

$

0.16

 

 

 

 

 

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)

 

 

 

 

 

 

 

April 30, 2025

 

October 31, 2024

ASSETS

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

62,626

 

 

$

97,744

 

Restricted Cash

 

 

2,171

 

 

 

5,251

 

Accounts receivable, net

 

 

195,264

 

 

 

197,689

 

Inventories

 

 

279,482

 

 

 

275,550

 

Income taxes receivable

 

 

6,108

 

 

 

5,937

 

Prepaid and other current assets

 

 

42,825

 

 

 

29,097

 

Total current assets

 

 

588,476

 

 

 

611,268

 

Property, plant and equipment, net

 

 

417,104

 

 

 

402,466

 

Operating lease right-of-use assets

 

 

149,322

 

 

 

126,715

 

Deferred tax assets

 

 

4,049

 

 

 

3,845

 

Goodwill

 

 

579,110

 

 

 

574,711

 

Intangible assets, net

 

 

567,148

 

 

 

597,909

 

Other assets

 

 

3,057

 

 

 

2,874

 

Total assets

 

$

2,308,266

 

 

$

2,319,788

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

$

112,484

 

 

$

124,404

 

Accrued liabilities

 

 

91,573

 

 

 

103,623

 

Income taxes payable

 

 

-

 

 

 

6,620

 

Current maturities of long-term debt

 

 

26,124

 

 

 

25,745

 

Current operating lease liabilities

 

 

14,184

 

 

 

12,475

 

Total current liabilities

 

 

244,365

 

 

 

272,867

 

Long-term debt

 

 

746,387

 

 

 

737,198

 

Noncurrent operating lease liabilities

 

 

139,955

 

 

 

117,560

 

Deferred income taxes

 

 

163,591

 

 

 

162,304

 

Other liabilities

 

 

12,305

 

 

 

19,113

 

Total liabilities

 

 

1,306,603

 

 

 

1,309,042

 

Stockholders’ equity:

 

 

 

 

Common stock

 

 

512

 

 

 

513

 

Additional paid-in-capital

 

 

698,238

 

 

 

701,008

 

Retained earnings

 

 

428,483

 

 

 

430,405

 

Accumulated other comprehensive loss

 

 

(27,034

)

 

 

(46,428

)

Treasury stock at cost

 

 

(98,536

)

 

 

(74,752

)

Total stockholders’ equity

 

 

1,001,663

 

 

 

1,010,746

 

Total liabilities and stockholders' equity

 

$

2,308,266

 

 

$

2,319,788

 

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(In thousands)
(Unaudited)

 

 

 

 

 

Six Months Ended April 30,

 

 

2025

 

 

 

2024

 

Operating activities:

 

 

 

Net income

$

5,630

 

 

$

21,626

 

Adjustments to reconcile net income to cash provided by operating activities:

 

 

 

Depreciation and amortization

 

43,932

 

 

 

22,046

 

Stock-based compensation

 

1,825

 

 

 

1,365

 

Deferred income tax

 

1,250

 

 

 

(155

)

Other, net

 

7,243

 

 

 

162

 

Changes in assets and liabilities:

 

 

 

Decrease in accounts receivable

 

5,322

 

 

 

10,832

 

Increase in inventory

 

(1,333

)

 

 

(3,008

)

Increase in other current assets

 

(7,828

)

 

 

(1,124

)

Decrease in accounts payable

 

(14,771

)

 

 

(12,619

)

Decrease in accrued liabilities

 

(14,048

)

 

 

(4,602

)

(Decrease) increase in income taxes receivable

 

(5,471

)

 

 

1,856

 

(Decrease) increase in other long-term liabilities

 

(6,268

)

 

 

9

 

Other, net

 

504

 

 

 

557

 

Cash provided by operating activities

 

15,987

 

 

 

36,945

 

Investing activities:

 

 

 

Capital expenditures

 

(26,544

)

 

 

(17,183

)

Proceeds from disposition of capital assets

 

376

 

 

 

93

 

Cash used for investing activities

 

(26,168

)

 

 

(17,090

)

Financing activities:

 

 

 

Borrowings under credit facilities

 

125,000

 

 

 

-

 

Repayments of credit facility borrowings

 

(117,500

)

 

 

(15,000

)

Repayments of other long-term debt

 

(1,888

)

 

 

(954

)

Common stock dividends paid

 

(7,552

)

 

 

(5,294

)

Issuance of common stock

 

214

 

 

 

554

 

Payroll tax paid to settle shares forfeited upon vesting of stock

 

(1,400

)

 

 

(1,193

)

Purchase of treasury stock

 

(27,194

)

 

 

-

 

Cash used for financing activities

 

(30,320

)

 

 

(21,887

)

Effect of exchange rate changes on cash and cash equivalents

 

2,303

 

 

 

(293

)

Decrease in cash, cash equivalents and restricted cash

 

(38,198

)

 

 

(2,325

)

Cash, cash equivalents and restricted cash at beginning of period

 

102,995

 

 

 

58,474

 

Cash, cash equivalents and restricted cash at end of period

$

64,797

 

 

$

56,149

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION
FREE CASH FLOW AND NET DEBT RECONCILIATION
(In thousands)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended April 30,

 

Six Months Ended April 30,

 

 

 

 

2025

 

2024

 

2025

 

2024

 

Cash provided by operating activities

 

 

$28,497

 

$33,091

 

$15,987

 

$36,945

 

Capital expenditures

 

 

(14,920)

 

(7,603)

 

(26,544)

 

(17,183)

 

Free Cash Flow

 

 

$13,577

 

$25,488

 

($10,557)

 

$19,762

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of April 30,

 

 

 

 

 

 

2025

 

2024

 

 

 

 

 

Term loan facility

 

 

$481,205

 

$0

 

 

 

 

 

Revolving credit facility

 

 

242,500

 

-

 

 

 

 

 

Finance lease obligations (1)

 

 

61,272

 

55,217

 

 

 

 

 

Total debt (2)

 

 

784,977

 

55,217

 

 

 

 

 

Less: Cash and cash equivalents

 

 

62,626

 

56,149

 

 

 

 

 

Net Debt

 

 

$722,351

 

($932)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Includes $57.4 million and $51.0 million in real estate lease liabilities considered finance leases under U.S. GAAP as of April 30 2025 and 2024, respectively.

 

 

 

 

 

(2) Excludes outstanding letters of credit.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION
(In thousands, except per share data)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Last Twelve Months Adjusted EBITDA

 

Three Months Ended
April 30, 2025

 

Three Months Ended
January 31, 2025

 

Three Months Ended
October 31, 2024

 

Three Months Ended
July 31, 2024

 

Total

 

 

Reconciliation

 

Reconciliation

 

Reconciliation

 

Reconciliation

 

Reconciliation

Net income (loss) as reported

 

$

20,515

 

$

(14,885

)

 

$

(13,917

)

 

$

25,350

 

 

$

17,063

 

Income tax expense (benefit)

 

 

6,307

 

 

(5,050

)

 

 

(3,621

)

 

 

6,688

 

 

 

4,324

 

Other, net

 

 

159

 

 

(1,229

)

 

 

2,671

 

 

 

(9,474

)

 

 

(7,873

)

Interest expense

 

 

13,940

 

 

14,186

 

 

 

17,697

 

 

 

878

 

 

 

46,701

 

Depreciation and amortization

 

 

19,192

 

 

24,740

 

 

 

27,329

 

 

 

10,953

 

 

 

82,214

 

EBITDA

 

 

60,113

 

 

17,762

 

 

 

30,159

 

 

 

34,395

 

 

 

142,429

 

Cost of sales (1)

 

 

-

 

 

-

 

 

 

887

 

 

 

1,507

 

 

 

2,394

 

Selling, general and administrative (1),(2),(3)

 

 

864

 

 

12,876

 

 

 

50,004

 

 

 

6,133

 

 

 

69,877

 

Restructuring charges (4)

 

 

936

 

 

7,904

 

 

 

-

 

 

 

-

 

 

 

8,840

 

Adjusted EBITDA

 

$

61,913

 

$

38,542

 

 

$

81,050

 

 

$

42,035

 

 

$

223,540

 

 

 

 

 

 

 

 

 

 

 

 

(1) Expense (gain) related to plant closure.

(2) Transaction, advisory fees, and reorganization costs.

(3) Amortization of step-up for purchase price adjustments on inventory.

(4) Restructuring charges related to severeance and disposal of software.

 

 

 

 

 

 

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
(In thousands, except per share data)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Adjusted Net Income and Adjusted EPS

Three Months Ended
April 30, 2025

 

Three Months Ended
April 30, 2024

 

Six Months Ended
April 30, 2025

 

Six Months Ended
April 30, 2024

 

 

 

Net Income

 

Diluted EPS

 

Net Income

 

Diluted EPS

 

Net Income

 

Diluted EPS

 

Net Income

 

Diluted EPS

 

Net income as reported

 

$

20,515

 

 

$

0.44

 

 

$

15,377

 

 

$

0.46

 

 

$

5,630

 

 

$

0.12

 

 

$

21,626

 

 

$

0.65

 

 

Net income reconciling items from below

 

 

7,372

 

 

$

0.16

 

 

 

8,664

 

 

$

0.27

 

 

 

31,218

 

 

$

0.67

 

 

 

10,680

 

 

$

0.33

 

 

Adjusted net income and adjusted EPS

 

$

27,887

 

 

$

0.60

 

 

$

24,041

 

 

$

0.73

 

 

$

36,848

 

 

$

0.79

 

 

$

32,306

 

 

$

0.98

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Adjusted EBITDA

 

Three Months Ended
April 30, 2025

 

Three Months Ended
April 30, 2024

 

Six Months Ended
April 30, 2025

 

Six Months Ended
April 30, 2024

 

 

 

Reconciliation

 

 

 

Reconciliation

 

 

 

Reconciliation

 

 

 

Reconciliation

 

 

 

Net income as reported

 

$

20,515

 

 

 

 

$

15,377

 

 

 

 

$

5,630

 

 

 

 

$

21,626

 

 

 

 

Income tax (benefit) expense

 

 

6,307

 

 

 

 

 

4,314

 

 

 

 

 

1,257

 

 

 

 

 

5,956

 

 

 

 

Other, net

 

 

159

 

 

 

 

 

(4

)

 

 

 

 

(1,070

)

 

 

 

 

(1,046

)

 

 

 

Interest expense

 

 

13,940

 

 

 

 

 

950

 

 

 

 

 

28,126

 

 

 

 

 

2,018

 

 

 

 

Depreciation and amortization

 

 

19,192

 

 

 

 

 

10,894

 

 

 

 

 

43,932

 

 

 

 

 

22,046

 

 

 

 

EBITDA

 

 

60,113

 

 

 

 

 

31,531

 

 

 

 

 

77,875

 

 

 

 

 

50,600

 

 

 

 

EBITDA reconciling items from below

 

 

1,800

 

 

 

 

 

8,493

 

 

 

 

 

22,579

 

 

 

 

 

8,698

 

 

 

 

Adjusted EBITDA

 

$

61,913

 

 

 

 

$

40,024

 

 

 

 

$

100,454

 

 

 

 

$

59,298

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciling Items

 

Three Months Ended
April 30, 2025

 

Three Months Ended
April 30, 2024

 

Six Months Ended
April 30, 2025

 

Six Months Ended
April 30, 2024

 

 

 

Income Statement

 

Reconciling Items

 

Income Statement

 

Reconciling Items

 

Income Statement

 

Reconciling Items

 

Income Statement

 

Reconciling Items

 

Net sales

 

$

452,478

 

 

$

-

 

 

$

266,201

 

 

$

-

 

 

$

852,522

 

 

$

-

 

 

$

505,356

 

 

$

-

 

 

Cost of sales

 

 

321,096

 

 

 

-

 

 

 

199,963

 

 

 

(631

)

(1)

 

628,824

 

 

 

-

 

 

 

387,686

 

 

 

(631

)

(1)

Selling, general and administrative

 

 

70,333

 

 

 

(864

)

(2)

 

34,707

 

 

 

(7,862

)

(1),(2)

 

136,983

 

 

 

(13,739

)

(2),(3)

 

67,070

 

 

 

(8,067

)

(1),(2)

Restructuring charges

 

 

936

 

 

 

(936

)

(4)

 

-

 

 

 

-

 

 

 

8,840

 

 

 

(8,840

)

(4)

 

-

 

 

 

-

 

 

EBITDA

 

 

60,113

 

 

 

1,800

 

 

 

31,531

 

 

 

8,493

 

 

 

77,875

 

 

 

22,579

 

 

 

50,600

 

 

 

8,698

 

 

Depreciation and amortization

 

 

19,192

 

 

 

(6,451

)

(5)

 

10,894

 

 

 

(2,956

)

(5)

 

43,932

 

 

 

(17,101

)

(5)

 

22,046

 

 

 

(6,185

)

(5)

Operating income

 

 

40,921

 

 

 

8,251

 

 

 

20,637

 

 

 

11,449

 

 

 

33,943

 

 

 

39,680

 

 

 

28,554

 

 

 

14,883

 

 

Interest expense

 

 

(13,940

)

 

 

-

 

 

 

(950

)

 

 

-

 

 

 

(28,126

)

 

 

-

 

 

 

(2,018

)

 

 

-

 

 

Other, net

 

 

(159

)

 

 

1,003

 

(6)

 

4

 

 

 

(92

)

(6)

 

1,070

 

 

 

831

 

(6)

 

1,046

 

 

 

(847

)

(6)

Income before income taxes

 

 

26,822

 

 

 

9,254

 

 

 

19,691

 

 

 

11,357

 

 

 

6,887

 

 

 

40,511

 

 

 

27,582

 

 

 

14,036

 

 

Income tax expense

 

 

(6,307

)

 

 

(1,882

)

(7)

 

(4,314

)

 

 

(2,693

)

(7)

 

(1,257

)

 

 

(9,293

)

(7)

 

(5,956

)

 

 

(3,356

)

(7)

Net income

 

$

20,515

 

 

$

7,372

 

 

$

15,377

 

 

$

8,664

 

 

$

5,630

 

 

$

31,218

 

 

$

21,626

 

 

$

10,680

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share

 

$

0.44

 

 

 

 

$

0.46

 

 

 

 

$

0.12

 

 

 

 

$

0.65

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Expense (gain) related to plant closure.

 

(2) Transaction, advisory fees, and reorganization costs.

 

(3) Amortization of step-up for purchase price adjustments on inventory.

 

(4) Restructuring charges related to severeance and disposal of software.

 

(5) Amortization expense related to intangible assets.

 

(6) Pension settlement refund and foreign currency transaction losses (gains).

 

(7) Tax impact of net income reconciling items.

 


QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA
(In thousands)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.

 

 

NA Fenestration

 

EU Fenestration

 

NA Cabinet Components

 

Tyman

 

Unallocated Corp & Other

 

Total

Three months ended April 30, 2025

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

151,026

 

 

$

61,257

 

 

$

51,237

 

 

$

190,107

 

 

$

(1,149

)

 

$

452,478

 

Cost of sales

 

 

113,760

 

 

 

39,001

 

 

 

42,405

 

 

 

126,743

 

 

 

(813

)

 

 

321,096

 

Gross Margin

 

 

37,266

 

 

 

22,256

 

 

 

8,832

 

 

 

63,364

 

 

 

(336

)

 

 

131,382

 

Gross Margin %

 

 

24.7%

 

 

 

36.3%

 

 

 

17.2%

 

 

 

33.3%

 

 

 

 

 

29.0%

 

Selling, general and administrative (1)

 

 

15,938

 

 

 

9,038

 

 

 

5,725

 

 

 

37,271

 

 

 

2,361

 

 

 

70,333

 

Restructuring charges

 

 

-

 

 

 

-

 

 

 

-

 

 

 

936

 

 

 

-

 

 

 

936

 

Depreciation and amortization

 

 

4,667

 

 

 

2,659

 

 

 

3,015

 

 

 

8,775

 

 

 

76

 

 

 

19,192

 

Operating income (loss)

 

 

16,661

 

 

 

10,559

 

 

 

92

 

 

 

16,382

 

 

 

(2,773

)

 

 

40,921

 

Depreciation and amortization

 

 

4,667

 

 

 

2,659

 

 

 

3,015

 

 

 

8,775

 

 

 

76

 

 

 

19,192

 

EBITDA

 

 

21,328

 

 

 

13,218

 

 

 

3,107

 

 

 

25,157

 

 

 

(2,697

)

 

 

60,113

 

Transaction, advisory fees, and reorganization costs

 

 

-

 

 

 

-

 

 

 

-

 

 

 

675

 

 

 

189

 

 

 

864

 

Restructuring charges related to severance and disposal of software

 

 

-

 

 

 

-

 

 

 

-

 

 

 

936

 

 

 

-

 

 

 

936

 

Adjusted EBITDA

 

$

21,328

 

 

$

13,218

 

 

$

3,107

 

 

$

26,768

 

 

$

(2,508

)

 

$

61,913

 

Adjusted EBITDA Margin %

 

 

14.1%

 

 

 

21.6%

 

 

 

6.1%

 

 

 

14.1%

 

 

 

 

 

13.7%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended April 30, 2024

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

159,774

 

 

$

56,583

 

 

$

51,078

 

 

$

-

 

 

$

(1,234

)

 

$

266,201

 

Cost of sales

 

 

122,261

 

 

 

35,694

 

 

 

42,624

 

 

 

-

 

 

 

(616

)

 

 

199,963

 

Gross Margin

 

 

37,513

 

 

 

20,889

 

 

 

8,454

 

 

 

-

 

 

 

(618

)

 

 

66,238

 

Gross Margin %

 

 

23.5%

 

 

 

36.9%

 

 

 

16.6%

 

 

 

 

 

 

 

24.9%

 

Selling, general and administrative (1)

 

 

13,730

 

 

 

7,873

 

 

 

5,066

 

 

 

-

 

 

 

8,038

 

 

 

34,707

 

Depreciation and amortization

 

 

5,218

 

 

 

2,538

 

 

 

3,082

 

 

 

-

 

 

 

56

 

 

 

10,894

 

Operating income (loss)

 

 

18,565

 

 

 

10,478

 

 

 

306

 

 

 

-

 

 

 

(8,712

)

 

 

20,637

 

Depreciation and amortization

 

 

5,218

 

 

 

2,538

 

 

 

3,082

 

 

 

-

 

 

 

56

 

 

 

10,894

 

EBITDA

 

 

23,783

 

 

 

13,016

 

 

 

3,388

 

 

 

-

 

 

 

(8,656

)

 

 

31,531

 

Expense related to plant closure (Cost of sales)

 

 

631

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

631

 

Expense related to plant closure (SG&A)

 

 

978

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

978

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

6,884

 

 

 

6,884

 

Adjusted EBITDA

 

$

25,392

 

 

$

13,016

 

 

$

3,388

 

 

$

-

 

 

$

(1,772

)

 

$

40,024

 

Adjusted EBITDA Margin %

 

 

15.9%

 

 

 

23.0%

 

 

 

6.6%

 

 

 

 

 

 

 

15.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six months ended April 30, 2025

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

285,359

 

 

$

109,728

 

 

$

95,047

 

 

$

365,783

 

 

$

(3,395

)

 

$

852,522

 

Cost of sales

 

 

220,327

 

 

 

69,638

 

 

 

81,821

 

 

 

259,539

 

 

 

(2,501

)

 

 

628,824

 

Gross Margin

 

 

65,032

 

 

 

40,090

 

 

 

13,226

 

 

 

106,244

 

 

 

(894

)

 

 

223,698

 

Gross Margin %

 

 

22.8%

 

 

 

36.5%

 

 

 

13.9%

 

 

 

29.0%

 

 

 

 

 

26.2%

 

Selling, general and administrative (1)

 

 

32,071

 

 

 

16,959

 

 

 

10,992

 

 

 

71,649

 

 

 

5,312

 

 

 

136,983

 

Restructuring charges

 

 

-

 

 

 

-

 

 

 

-

 

 

 

8,840

 

 

 

-

 

 

 

8,840

 

Depreciation and amortization

 

 

9,446

 

 

 

5,269

 

 

 

6,024

 

 

 

23,038

 

 

 

155

 

 

 

43,932

 

Operating income (loss)

 

 

23,515

 

 

 

17,862

 

 

 

(3,790

)

 

 

2,717

 

 

 

(6,361

)

 

 

33,943

 

Depreciation and amortization

 

 

9,446

 

 

 

5,269

 

 

 

6,024

 

 

 

23,038

 

 

 

155

 

 

 

43,932

 

EBITDA

 

 

32,961

 

 

 

23,131

 

 

 

2,234

 

 

 

25,755

 

 

 

(6,206

)

 

 

77,875

 

Amortization of step-up for purchase price adjustments on inventory

 

 

-

 

 

 

-

 

 

 

-

 

 

 

9,007

 

 

 

-

 

 

 

9,007

 

Transaction, advisory fees, and reorganization costs

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,142

 

 

 

2,590

 

 

 

4,732

 

Restructuring charges related to severance and disposal of software

 

 

-

 

 

 

-

 

 

 

-

 

 

 

8,840

 

 

 

-

 

 

 

8,840

 

Adjusted EBITDA

 

$

32,961

 

 

$

23,131

 

 

$

2,234

 

 

$

45,744

 

 

$

(3,616

)

 

$

100,454

 

Adjusted EBITDA Margin %

 

 

11.6%

 

 

 

21.1%

 

 

 

2.4%

 

 

 

12.5%

 

 

 

 

 

11.8%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six months ended April 30, 2024

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

307,769

 

 

$

106,020

 

 

$

94,215

 

 

$

-

 

 

$

(2,648

)

 

$

505,356

 

Cost of sales

 

 

240,629

 

 

 

67,397

 

 

 

81,367

 

 

 

-

 

 

 

(1,707

)

 

 

387,686

 

Gross Margin

 

 

67,140

 

 

 

38,623

 

 

 

12,848

 

 

 

-

 

 

 

(941

)

 

 

117,670

 

Gross Margin %

 

 

21.8%

 

 

 

36.4%

 

 

 

13.6%

 

 

 

 

 

 

 

23.3%

 

Selling, general and administrative (1)

 

 

29,640

 

 

 

15,618

 

 

 

10,192

 

 

 

-

 

 

 

11,620

 

 

 

67,070

 

Depreciation and amortization

 

 

10,693

 

 

 

5,096

 

 

 

6,147

 

 

 

-

 

 

 

110

 

 

 

22,046

 

Operating income (loss)

 

 

26,807

 

 

 

17,909

 

 

 

(3,491

)

 

 

-

 

 

 

(12,671

)

 

 

28,554

 

Depreciation and amortization

 

 

10,693

 

 

 

5,096

 

 

 

6,147

 

 

 

-

 

 

 

110

 

 

 

22,046

 

EBITDA

 

 

37,500

 

 

 

23,005

 

 

 

2,656

 

 

 

-

 

 

 

(12,561

)

 

 

50,600

 

Expense related to plant closure (Cost of sales)

 

 

631

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

631

 

Expense related to plant closure (SG&A)

 

 

978

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

978

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

7,089

 

 

 

7,089

 

Adjusted EBITDA

 

$

39,109

 

 

$

23,005

 

 

$

2,656

 

 

$

-

 

 

$

(5,472

)

 

$

59,298

 

Adjusted EBITDA Margin %

 

 

12.7%

 

 

 

21.7%

 

 

 

2.8%

 

 

 

 

 

 

 

11.7%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Includes stock-based compensation expense for the three and six months ended April 30, 2025, respectively of $0.6 million and $1.8 million and $1.5 million and $4.1 million for the comparable prior year periods.

 

 

 

 

 

 

 

 

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION
SALES ANALYSIS
(In thousands)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended April 30,

 

Six Months Ended April 30,

 

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

 

 

 

 

 

 

 

NA Fenestration:

 

 

 

 

 

 

 

 

United States - fenestration

$

112,261

 

 

$

119,646

 

 

$

212,690

 

 

$

231,280

 

 

International - fenestration

 

8,054

 

 

 

7,465

 

 

 

13,913

 

 

 

13,609

 

 

United States - non-fenestration

 

26,751

 

 

 

27,532

 

 

 

49,956

 

 

 

53,323

 

 

International - non-fenestration

 

3,960

 

 

 

5,131

 

 

 

8,800

 

 

 

9,557

 

 

 

$

151,026

 

 

$

159,774

 

 

$

285,359

 

 

$

307,769

 

EU Fenestration: (1)

 

 

 

 

 

 

 

 

International - fenestration

$

50,687

 

 

$

46,968

 

 

$

92,743

 

 

$

88,719

 

 

International - non-fenestration

 

10,570

 

 

 

9,615

 

 

 

16,985

 

 

 

17,301

 

 

 

$

61,257

 

 

$

56,583

 

 

$

109,728

 

 

$

106,020

 

NA Cabinet Components:

 

 

 

 

 

 

 

 

United States - fenestration

$

3,507

 

 

$

3,737

 

 

$

6,959

 

 

$

7,412

 

 

United States - non-fenestration

 

47,364

 

 

 

46,990

 

 

 

87,427

 

 

 

86,169

 

 

International - non-fenestration

 

366

 

 

 

351

 

 

 

661

 

 

 

634

 

 

 

$

51,237

 

 

$

51,078

 

 

$

95,047

 

 

$

94,215

 

Tyman:

 

 

 

 

 

 

 

 

United States - fenestration

$

113,950

 

 

$

-

 

 

$

219,541

 

 

$

-

 

 

International - fenestration

 

75,547

 

 

 

-

 

 

 

144,829

 

 

 

-

 

 

United States - non-fenestration

 

610

 

 

 

-

 

 

 

1,395

 

 

 

-

 

 

International - non-fenestration

 

-

 

 

 

-

 

 

 

18

 

 

 

-

 

 

 

$

190,107

 

 

$

-

 

 

$

365,783

 

 

$

-

 

 

 

 

 

 

 

 

 

 

Unallocated Corporate & Other:

 

 

 

 

 

 

 

 

Eliminations

$

(1,149

)

 

$

(1,234

)

 

$

(3,395

)

 

$

(2,648

)

 

 

$

(1,149

)

 

$

(1,234

)

 

$

(3,395

)

 

$

(2,648

)

 

 

 

 

 

 

 

 

 

Net Sales

$

452,478

 

 

$

266,201

 

 

$

852,522

 

 

$

505,356

 

 

 

 

 

 

 

 

 

 

(1) Reflects an increase of $0.2 million in revenue associated with foreign currency exchange rate impacts for the three and six months ended April 30, 2025, respectively.